Filing Flows › Pure Bioscience (PURE) › Q4 FY26 › vs Q4 FY25
Pure Bioscience (PURE) Q4 FY26 vs Q4 FY25 (year over year)
Pure Bioscience's revenue fell $104K (-14%) from $763K in Q4 FY25 to $659K in Q4 FY26.
Pure Bioscience, Q4 FY26: revenue $659K (-14% year over year), operating margin -76.3%, net loss $610K, operating cash flow −$414K. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $659K | $763K | −$104K | -14% |
| Net loss | $610K | $332K | $278K | +84% |
| Costs & expenses | $1.3M | $1.1M | $170K | +15% |
| Operating costs | $1.2M | $1.1M | $63K | +6% |
| Interest & other, net | $107K | −$4K | $111K | — |
| Cost of revenue | $290K | $295K | −$5K | -2% |
| Research & development | $93K | $73K | $20K | +27% |
| SG&A | $779K | $731K | $48K | +7% |
| Operating cash sources | $610K | $332K | $278K | +84% |
| Depreciation | $1K | $0 | $1K | — |
| Share-based compensation | $50K | $30K | $20K | +67% |
| Working capital & other | $145K | −$154K | $299K | — |
| Cash used in operations | $414K | $456K | −$42K | -9% |
| Net loss absorbed | $610K | $332K | $278K | +84% |
Questions
How much did Pure Bioscience's revenue grow year over year in Q4 FY26?
Pure Bioscience's revenue fell $104K (-14%) from $763K in Q4 FY25 to $659K in Q4 FY26.